Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with schizophrenia - Richards, A A; Hickman, I J; Wang, A Y (J Clin Psychopharmacol, 2006)
et al.